(Q33402882)

26 July 2017

title

A randomized controlled trial of romiplostim in patients with low- or intermediate-risk myelodysplastic syndrome receiving decitabine (English)

1 reference

randomized controlled trial

26 July 2017

main subject

1 reference

1 reference

myelodysplastic syndrome

1 reference

based on heuristic

inferred from title

author

Guillermo Garcia-Manero

2

object named as

Guillermo Garcia-Manero

1 reference

26 July 2017

Peter L Greenberg

1

1 reference

26 July 2017

Michael Moore

3

1 reference

26 July 2017

Lloyd Damon

4

1 reference

26 July 2017

Gail Roboz

5

1 reference

26 July 2017

Kuolung Hu

6

1 reference

26 July 2017

Allen S Yang

7

1 reference

26 July 2017

Janet Franklin

8

1 reference

26 July 2017

publication date

15 November 2012

1 reference

26 July 2017

1 reference

26 July 2017

volume

54

1 reference

26 July 2017

issue

2

1 reference

26 July 2017

page(s)

321-328

1 reference

Myelodysplastic syndromes: biology and treatment

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.713477

International MDS risk analysis workshop (IMRAW)/IPSS reanalyzed: impact of cytopenias on clinical outcomes in myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.713477

The incidence and impact of thrombocytopenia in myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.713477

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.713477

Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.713477

Safety and efficacy of romiplostim in patients with lower-risk myelodysplastic syndrome and thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.713477

Subcutaneous or intravenous administration of romiplostim in thrombocytopenic patients with lower risk myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.713477

Changes in DNA methylation in neoplasia: pathophysiology and therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.713477

Reactivation of epigenetically silenced genes by DNA methyltransferase inhibitors: basic concepts and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.713477

Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.713477

Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.713477

Multicenter study of decitabine administered daily for 5 days every 4 weeks to adults with myelodysplastic syndromes: the alternative dosing for outpatient treatment (ADOPT) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.713477

Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.713477

Phase 2 study of romiplostim in patients with low- or intermediate-risk myelodysplastic syndrome receiving azacitidine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.713477

The World Health Organization (WHO) classification of the myeloid neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.713477

Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.713477

The role of azacitidine in the treatment of myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.713477

Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.713477

10.3109/10428194.2012.713477

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference